SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-001425
Filing Date
2024-01-16
Accepted
2024-01-16 18:06:55
Documents
1
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1705446400.html 4  
1 FORM 4 wk-form4_1705446400.xml 4 6268
  Complete submission text file 0001628280-24-001425.txt   8026
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NEORX CORP 410 WEST HARRISON ST SEATTLE WA 98119
Business Address
GIVEN DOUGLAS B (Reporting) CIK: 0001156207 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 24536302